| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |